≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of uteri, other/unspecified

Endpoint Browser

CD2_INSITU_CERVIX_UTERI_NOS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only females

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D06.7&, D06.9&
  • Hospital discharge: ICD-9 — 2331
  • Cause of death: ICD-10 — D06.7&, D06.9&
  • Cause of death: ICD-9 — 2331

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 227 227 -
Unadjusted period prevalence (%) 0.08 0.08 -
Median age at first event (years) 35.79 35.79 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
212
Matched controls
2120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
1404.1
166.6
141
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
+∞
138.1
117
*
2331A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Cervix uteri
+∞
109.0
95
*
8326
FHL
Batch conization
118.5
57.4
60
7
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
12.8
34.1
64
69
ULA02
NOMESCO Finland
Kolposcopy
7.1
30.7
89
197
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
7.2
30.6
87
187
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
77.6
29.9
33
5
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
18.0
25.5
40
27
LDA10
NOMESCO Finland
Curettage of cervix uteri
9.4
22.2
48
64
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.0
21.2
80
227
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.9
17.5
53
114
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
54.9
17.3
20
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
+∞
14.8
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.7
13
*
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
137.8
12.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.6
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
115.5
10.5
11
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
31.6
9.5
12
*
HAC20
NOMESCO Finland
Total mastectomy
104.5
9.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
9.6
8.7
17
19
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
8.4
8
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
8.4
8
*
D06.7
ICD-10 Finland
Carcinoma in situ: Other parts of cervix
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
82.9
7.5
8
*
L02BA01
ATC
tamoxifen; oral
82.9
7.5
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
71.9
6.5
7
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
71.9
6.5
7
*
H02AB02
ATC
dexamethasone; systemic
11.5
6.4
11
10
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
6.3
6
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
79
459
2.11
6.26
1.8
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
38
4.16
5.53
2.3
1.8
—
—
—
0
0
(4035726)
16
43
3.93
5.47
1.9
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
36
3.46
3.53
1.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
75
517
1.67
3.15
2.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
110
2.11
2.51
2.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
92
702
1.52
2.41
2.1
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
85
2.08
1.96
8.2
2.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
60
435
1.52
1.95
3.2
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
146
1.80
1.87
3.1
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
96
774
1.42
1.78
3.7
3.5
—
—
—
0
0
(4034850)
15
75
2.07
1.74
9.7
5.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
215
1.63
1.69
1.6
1.6
%
1.3
1.3
0.01
28
188
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
1942
0.66
1.60
4.2
4.3
mmol/l
5.9
5.8
0.61
169
1812
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
22
130
1.77
1.60
9.4
4.3
u/l
233.4
241.5
0.15
22
121
(3027008) Opiates [Presence] in Urine
13
64
2.09
1.57
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
64
2.09
1.57
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
64
2.09
1.57
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
64
2.09
1.57
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
228
0.50
1.56
4.2
4.3
%
28.7
33.5
—
7
155
(3045414) Leukocytes [Presence] in Urine
16
86
1.93
1.54
1.8
1.9
—
—
—
0
0
(44813793)
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
44
0.00
1.53
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
404
0.62
1.50
1.2
1.3
g/l
1.9
2.4
2.07
18
238
(3020891) Body temperature
9
40
2.30
1.42
6.3
3.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
177
1898
0.69
1.41
5.4
5.1
mu/l
1.7
2.5
0.63
169
1780
(3002256) Pathology report gross observation
27
176
1.61
1.39
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
176
1.61
1.39
1.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
358
1.43
1.34
2.0
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
75
606
1.35
1.31
3.1
3.0
ng/l
196.0
16.9
0.81
34
359
(3013826) Glucose [Moles/volume] in Serum or Plasma
112
963
1.32
1.28
3.1
3.5
mmol/l
6.6
6.5
0.37
106
891
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
56
706
0.73
1.27
1.9
1.9
pmol/l
91.7
101.4
1.06
30
337
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
478
0.68
1.26
1.3
1.3
u/ml
2.1
2.3
0.04
11
137
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
780
1.33
1.26
4.5
4.8
mmol/l
1.2
1.2
0.38
81
671
(3014007) Fractional oxyhemoglobin in Arterial blood
12
63
1.96
1.25
4.1
9.0
%
91.9
94.1
0.71
12
63
(36660697) Celiac disease serology panel - Serum
9
170
0.51
1.24
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
455
1.37
1.21
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
134
1.62
1.19
1.5
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
33
0.00
1.17
0.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
39
2.09
1.16
5.5
3.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
182
0.53
1.16
2.7
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
65
1.89
1.16
4.1
8.7
%
0.8
0.6
0.85
12
65
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
181
0.53
1.14
2.5
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
58
1.94
1.14
4.5
2.9
%
48.1
45.2
0.13
11
58
(3015736) pH of Urine
88
743
1.30
1.11
4.1
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
32
2.22
1.09
1.3
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
168
1798
0.75
1.09
12.6
11.3
%
38.7
40.0
1.16
134
1392
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
172
1833
0.75
1.06
5.3
5.1
mmol/mol
39.0
38.8
0.14
161
1732
(3012544) pH of Venous blood
19
123
1.59
1.03
3.4
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
51
403
1.34
1.02
5.8
5.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.3
—
29.5
—
0
24
(3002032) Base excess in Venous blood by calculation
18
117
1.58
0.97
3.3
3.2
mmol/l
3.0
2.2
0.42
12
96
(3019225) pH of Specimen
8
144
0.54
0.97
3.9
3.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
51
1.80
0.95
1.3
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
27
2.25
0.94
1.0
1.0
—
0.3
—
0
6
(40768793) Breast Pathology biopsy report
6
27
2.25
0.94
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
57
464
1.31
0.93
2.2
2.7
ph
7.4
7.4
—
8
73
(3037522) Nuclear Ab [Titer] in Serum
22
309
0.68
0.92
1.8
1.3
titre
275.6
532.2
—
9
72
(3045424) Erythrocytes [Presence] in Urine
6
29
2.10
0.90
1.5
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
202
0.62
0.87
1.1
1.2
iu/ml
168.7
125.6
—
7
90
(3020630) Protein [Mass/volume] in Serum or Plasma
6
112
0.52
0.85
4.3
1.2
g/l
67.3
67.7
—
6
103
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
11
65
1.73
0.84
4.4
8.7
%
2.3
1.4
1.08
11
65
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
139
1.48
0.82
4.6
5.4
mmol/l
104.5
103.9
0.32
20
133
(3038515) Glucose [Moles/volume] in Venous blood
6
32
1.90
0.82
3.7
2.2
mmol/l
7.7
7.1
—
6
32
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
129
1402
0.81
0.78
2.9
3.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
34
1.78
0.77
3.7
2.2
mmol/l
1.4
1.4
—
6
34
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
7
38
1.87
0.74
5.0
4.2
mmol/l
1.5
1.2
—
7
38
(3021601) Nitrite [Presence] in Urine by Test strip
106
953
1.21
0.71
6.8
4.5
estimate
0.0
0.0
0.00
16
166
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
425
0.76
0.71
1.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
42
1.69
0.69
2.6
2.0
u/ml
8.0
10.6
—
7
35
(3009261) Glucose [Presence] in Urine by Test strip
106
958
1.20
0.66
4.6
3.3
estimate
0.0
0.0
0.80
15
164
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
20
147
1.40
0.64
5.3
3.0
pmol/l
4.6
4.6
0.18
20
131
(1002224) Polysomnography panel
6
102
0.58
0.64
1.3
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
142
1322
1.20
0.63
3.2
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
254
0.73
0.63
2.1
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
69
602
1.21
0.62
3.5
3.1
e6/l
9.9
67.8
3.05
51
396
(3023368) Bacteria identified in Blood by Culture
37
301
1.27
0.62
3.0
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
265
1.29
0.61
3.3
2.4
e6/l
1.1
1.1
0.02
23
139
(3050129) First trimester maternal screen panel - Serum or Plasma
8
51
1.59
0.61
1.6
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
20
0.00
0.60
0.0
2.0
—
48.3
—
0
14
(3032773) Endomysium IgG Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
201
2067
0.76
0.59
13.7
10.8
umol/l
67.1
68.3
0.49
201
2067
(3041096) Erythrocytes [Presence] in Urine by Automated
45
530
0.81
0.58
5.8
2.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
61
1.49
0.54
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
136
0.65
0.53
1.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
234
1.27
0.53
3.8
2.6
e6/l
5.6
3.9
0.45
19
108
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
9
64
1.42
0.52
1.6
1.4
pmol/l
58.0
53.5
—
9
64
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
564
0.83
0.50
1.5
1.7
mmol/l
1.5
1.4
0.30
41
478
(3019060) Gas panel - Arterial blood
10
67
1.52
0.50
4.0
4.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
84
1.45
0.50
1.1
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
158
1656
0.85
0.50
4.4
4.3
pmol/l
14.8
14.5
0.81
149
1550
(3028026) IgM [Mass/volume] in Serum or Plasma
7
107
0.64
0.50
1.0
1.4
g/l
1.5
1.3
—
7
98
(3014051) Protein [Presence] in Urine by Test strip
7
45
1.57
0.49
2.3
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
191
1968
0.81
0.48
12.2
10.9
mmol/l
3.9
3.9
0.41
186
1917
(3022621) pH of Urine by Test strip
15
111
1.38
0.48
5.3
2.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
129
1.34
0.47
1.2
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
164
0.72
0.47
2.4
2.4
—
19.8
—
0
6
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
85
0.58
0.46
1.0
2.1
u/l
36.8
40.8
—
5
78
(3019550) Sodium [Moles/volume] in Serum or Plasma
191
1964
0.83
0.43
12.1
10.8
mmol/l
139.8
140.0
0.24
186
1915
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
168
1.28
0.42
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
33
1.53
0.41
1.6
3.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
1.1
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
94.4
—
0
5
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
186
1915
0.84
0.41
11.2
9.8
mg/l
18.6
17.7
0.15
146
1426
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
34
1.48
0.40
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
18
0.00
0.40
0.0
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
8
61
1.32
0.40
2.6
8.3
mmol/l
24.2
24.9
—
8
61
(3044927) Protein electrophoresis panel - Urine
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
195
1998
0.83
0.39
4.0
4.3
mmol/l
5.0
5.0
0.22
185
1888
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
68
1.34
0.38
4.2
2.0
%
1.3
1.1
—
9
68
(3049717) Cytology report of Urine Cyto stain
5
37
1.36
0.37
4.6
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
37
1.36
0.37
1.4
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
140
1465
0.88
0.36
3.8
4.1
mm/h
11.6
10.9
0.29
134
1362
(3027945) Reticulocytes/100 erythrocytes in Blood
17
135
1.28
0.36
2.2
2.3
%
1.8
1.6
0.32
17
120
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
9
125
0.71
0.36
2.3
3.4
ng/l
48.8
76.2
—
9
108
(3029937) Albumin [Presence] in Urine by Test strip
55
494
1.15
0.36
3.6
3.4
estimate
0.0
0.0
0.00
16
170
(3019198) Lymphocytes [#/volume] in Blood
85
914
0.89
0.35
6.6
5.3
e9/l
2.0
2.0
0.15
78
813
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
86
0.69
0.33
3.5
3.5
kpa
5.3
5.4
—
6
79
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
429
1.15
0.33
1.2
1.3
iu/ml
28.6
34.0
0.16
21
145
(3021960) Folate [Moles/volume] in Serum or Plasma
34
388
0.85
0.33
1.4
1.5
nmol/l
22.3
22.6
0.03
29
328
(3005719) IgG [Mass/volume] in Serum or Plasma
10
131
0.75
0.31
1.2
2.1
g/l
10.9
10.4
—
10
126
(1761868) Lipid panel - Serum or Plasma
86
802
1.12
0.31
2.7
2.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
241
1.18
0.31
1.7
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
198
2019
0.85
0.30
4.5
4.8
mmol/l
3.0
2.9
0.07
186
1892
(3026008) Bacteria identified in Urine by Culture
60
549
1.13
0.30
3.1
2.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
227
0.82
0.30
2.6
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
227
0.82
0.30
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
167
1.22
0.29
1.5
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
100
943
1.11
0.29
4.1
3.2
estimate
0.0
0.0
0.00
14
170
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
158
1.22
0.29
1.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
158
1.22
0.29
1.3
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
46
508
0.88
0.29
2.7
3.0
mg/l
17.2
322.1
0.87
26
294
(42870588) Differential panel, method unspecified - Blood
51
559
0.89
0.28
5.9
5.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
103
976
1.10
0.27
10.4
6.8
e9/l
3.9
4.0
0.08
92
852
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
72
0.69
0.26
9.8
2.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
85
902
0.91
0.26
6.0
5.3
e9/l
0.0
0.0
0.12
76
779
(3002030) Lymphocytes/100 leukocytes in Blood
79
840
0.91
0.25
5.8
5.4
%
30.1
29.9
0.08
74
782
(3037467) Urinalysis macro (dipstick) panel - Urine
125
1301
0.91
0.25
4.7
4.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
195
1986
0.87
0.25
3.8
4.3
mmol/l
1.6
1.6
0.66
184
1869
(3000492) Spirometry study
21
180
1.18
0.25
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
6
84
0.71
0.24
3.5
3.5
—
7.4
—
0
14
(3018677) aPTT in Platelet poor plasma by Coagulation assay
23
200
1.17
0.23
2.7
2.1
s
29.0
29.7
0.28
23
192
(3026782) Osmolality of Urine
34
306
1.13
0.22
4.5
2.2
mosm/kgh2o
489.7
516.0
0.31
29
263
(40760892) CBC W Ordered Manual Differential panel - Blood
48
442
1.11
0.22
5.3
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
786
1.09
0.22
7.7
7.2
e9/l
0.0
0.0
0.72
72
648
(3008898) HLA-B27 [Presence]
8
101
0.78
0.21
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
103
0.77
0.21
2.5
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
11
0.00
0.21
0.0
1.7
—
10.1
—
0
11
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
1.6
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.6
—
92.2
—
0
10
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
88.2
—
0
10
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
8.6
—
0
12
(3001604) Monocytes [#/volume] in Blood
85
894
0.92
0.21
5.8
5.3
e9/l
0.5
0.5
0.53
76
777
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
52
559
0.91
0.21
2.8
2.1
u/l
49.6
57.2
1.17
46
514
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
1.1
—
0
13
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
144
0.82
0.20
1.2
1.3
—
38.0
—
0
9
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
12.3
—
0
9
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
56.2
—
0
9
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
62
582
1.09
0.19
3.3
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
51
1.18
0.19
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
206
0.86
0.19
2.3
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
233
1.13
0.18
1.9
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
205
2075
0.88
0.18
9.6
8.2
u/l
26.7
23.8
0.37
199
2017
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
67
0.74
0.17
1.8
1.6
mu/l
212.2
278.9
—
5
60
(40768443) Skin Pathology biopsy report
5
70
0.71
0.17
1.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
141
0.84
0.17
2.4
2.7
—
—
—
0
0
(4010399)
12
141
0.84
0.17
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
141
0.84
0.17
3.1
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
162
0.86
0.17
4.4
4.0
mmol/l
1.0
1.0
0.01
14
144
(3013115) Eosinophils [#/volume] in Blood
90
937
0.93
0.16
5.8
5.8
e9/l
0.2
0.2
1.13
80
836
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
78
0.76
0.16
1.0
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
60
568
1.08
0.16
10.0
6.3
inr
1.1
1.1
0.11
23
182
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
80
0.74
0.15
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
102
1.19
0.15
1.1
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
80
1.13
0.15
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
89
0.78
0.14
1.9
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
22
243
0.90
0.14
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
218
1.11
0.14
1.1
1.4
—
—
—
0
0
(3013512) EKG study
51
482
1.07
0.14
3.8
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
182
1846
0.93
0.13
11.0
8.5
ml/min/173m2
84.2
83.6
0.17
152
1491
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
219
1.11
0.13
5.0
4.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
56
533
1.07
0.13
4.2
3.7
mg/mmol
3.9
7.3
0.68
34
301
(3002582) Erythrocytes [#/volume] in Urine
50
474
1.07
0.12
3.3
2.6
e6/l
11.3
87.8
1.52
41
350
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
163
1.11
0.11
2.3
1.8
ml/min/173m2
66.4
72.2
—
8
73
(3025941) Bacteria identified in Stool by Culture
13
115
1.14
0.11
1.5
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
547
1.06
0.10
2.5
2.9
mmol/l
6.3
7.0
0.46
52
454
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
44
1.14
0.10
1.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
46
1.09
0.09
1.6
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
56
1.07
0.08
2.7
3.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
46
442
1.05
0.07
3.3
2.6
e6/l
0.2
0.5
2.10
36
323
(3019309) Folate [Moles/volume] in Red Blood Cells
25
265
0.94
0.07
1.5
1.6
nmol/l
1343.1
1149.7
0.48
20
197
(3022145) Colonoscopy Study observation
21
197
1.07
0.06
1.4
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
104
0.86
0.06
2.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
29
304
0.95
0.06
2.1
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
134
1357
0.97
0.05
7.2
5.1
u/l
77.5
75.8
0.27
129
1249
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
424
0.96
0.05
3.5
2.0
mg/l
1.3
0.9
0.50
34
327
(3042936) Bacteria identified in Isolate by Culture
21
221
0.95
0.04
2.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
91
1.10
0.04
4.6
7.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1901
0.97
0.03
3.5
3.9
mmol/l
1.3
1.2
0.30
174
1778
(3000850) Epithelial cells [#/volume] in Urine
33
340
0.97
0.03
1.8
2.0
e6/l
2.5
7.9
6.76
27
300
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
231
1.04
0.03
1.3
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
32
312
1.03
0.02
2.5
3.5
ng/l
51.3
303.4
0.63
18
217
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
53
537
0.98
0.01
2.0
1.9
u/l
171.8
121.1
0.40
53
511
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
747
0.99
0.01
5.2
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
284
1.02
0.00
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
204
2041
1.00
0.00
10.9
9.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
429
1.00
0.00
1.3
1.3
u/ml
34.8
10.9
0.50
14
176
(3003338) MCHC [Mass/volume]
170
1702
1.00
0.00
16.2
13.0
g/l
331.6
331.0
0.37
170
1694
(3025159) Blasts/100 leukocytes in Blood
12
117
1.03
0.00
5.8
4.7
—
0.4
—
0
15
(36304419) Bacteria [Presence] in Urine
44
443
0.99
0.00
2.3
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
165
0.97
0.00
1.6
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
102.3
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
31.1
—
0
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
13.3
—
0
9
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
69
0.87
0.00
3.8
6.6
mmol/l
24.5
25.4
—
6
69
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
66
0.91
0.00
1.8
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.6
—
0
5
(3010375) cycloSPORINE [Mass/volume] in Blood
0
6
0.00
0.00
0.0
27.7
—
90.7
—
0
6
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
2.1
—
0
8
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
8
0.00
0.00
0.0
1.0
—
34.0
—
0
8
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
209.2
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
66
0.91
0.00
1.8
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
2195.2
—
0
6
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
2.8
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019977) pH of Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
50.1
—
0
7
(42529406) Shigella sp [Presence] in Stool by Culture
6
67
0.89
0.00
1.8
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
104.0
—
0
5
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
79
1.01
0.00
1.8
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
52
0.96
0.00
1.6
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.8
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_CERVIX_UTERI_NOS_EXALLC – Carcinoma in situ of uteri, other/unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).